- Home
- LEVI vs RGC Comparison
LEVI vs RGC Comparison
Compare LEVI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEVI | RGC |
|---|---|---|
| Founded | 1853 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Apparel | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 8.4B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LEVI | RGC |
|---|---|---|
| Price | $22.35 | $12.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $26.25 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 132.6K |
| Earning Date | 10-09-2025 | 10-24-2025 |
| Dividend Yield | ★ 2.51% | N/A |
| EPS Growth | ★ 303.84 | N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $6,589,400,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.20 | N/A |
| P/E Ratio | $14.74 | ★ N/A |
| Revenue Growth | ★ 11.22 | N/A |
| 52 Week Low | $12.17 | $0.09 |
| 52 Week High | $24.82 | $83.60 |
Technical Indicators
Market Signals| Indicator | LEVI | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 61.86 | 38.88 |
| Support Level | $19.88 | $10.33 |
| Resistance Level | $22.14 | $12.48 |
| Average True Range (ATR) | 0.59 | 1.06 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 85.14 | 36.99 |
Price Performance
Historical ComparisonAbout LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.